Measles Vaccination Campaign Underway: Nation Boasts Robust Vaccine Supply
A comprehensive measles vaccination campaign is underway nationwide, bolstered by a substantial vaccine inventory and a proactive public health strategy. As of January 23, 2026, over 12.2 million doses have been administered, with officials emphasizing sufficient supplies to meet the needs of prioritized populations and address potential outbreaks.
Extensive Vaccine Stockpile Ensures National Coverage
The Ministry of Health reports holding a current inventory of 23,529,075 measles vaccines, ensuring accessibility throughout the country. Furthermore, a total of 27,364,605 vaccines have been procured, demonstrating a commitment to maintaining a strong response capacity for both routine immunization and emerging epidemiological challenges. “Availability is sufficient,” a senior official stated, “and these doses are intended to complete vaccination schedules and bolster coverage among target and underserved groups.”
Who is Eligible for the Measles Vaccine?
The vaccination effort prioritizes several key demographics. Girls and boys at 1 year and 18 months are at the forefront, receiving doses crucial for establishing early childhood immunity and fostering community protection. A lagging population, encompassing children aged 2 to 9, is also being targeted, alongside individuals between 10 and 49 years old who lack documented proof of complete vaccination.
Beyond these core groups, the campaign extends to frontline workers including health personnel, educators, and agricultural laborers – a population identified as being at higher risk due to their frequent mobility and potential for exposure.
“Zero Dose” Strategy for Enhanced Protection
To further expand protection, particularly among the youngest citizens, the Ministry of Health is implementing a “zero dose” strategy. This involves administering a dose to children aged 6 to 11 months, especially in areas facing heightened epidemiological risk. In regions experiencing active measles outbreaks, a “0” dose is being provided to children aged 6 to 12 months as a rapid response measure to interrupt transmission chains and safeguard vulnerable infants.
Vigilant Surveillance and Rapid Response Protocols
The nation’s ability to effectively combat measles is underpinned by continuous epidemiological surveillance. The National Epidemiological Surveillance System allows for the timely detection of cases, laboratory confirmation, and identification of circulating genotypes, aligning with international health surveillance standards. This detailed monitoring enables the differentiation of imported cases from local transmission patterns, informing targeted interventions.
Following the detection of the first imported case on February 14, 2025, immediate action was taken, including the implementation of “epidemiological fences” – vaccination efforts within a 25-block radius of each confirmed case – and active case finding to identify potential associated infections. The vaccination age was also extended to 49 years, with a specific focus on agricultural laborers.
Public Awareness and International Collaboration
Efforts to increase vaccination rates are being supported by a robust public communication campaign utilizing radio, television, social media, and print media. The resumption of National Vaccination Weeks and National Public Health Week in 2025 further contributes to outreach and service delivery.
The Ministry of Health is also actively collaborating with the Pan American Health Organization (PAHO) and other international organizations, reinforcing a commitment to regional and global health standards in surveillance, containment, and outbreak response.
Call to Action: Check Your Vaccination Records
The Ministry of Health is urging families and caregivers to review the National Health Card and seek out medical units to complete any outstanding vaccinations. Officials reiterate that the measles vaccine is safe, free, and highly effective, emphasizing the importance of building confidence and increasing demand for immunization.
The agency has reaffirmed its dedication to containing transmission, minimizing complications, and preventing fatalities, prioritizing the protection of the most vulnerable populations. With readily available data on vaccine availability, procurement, and administration, the authority frames this initiative as a comprehensive programmatic and epidemiological response designed to maintain coverage and mitigate the risk of measles spread.
